We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+12.77%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$52.5B
AUM Growth
+$13.1B
(+33%)
Cap. Flow
+$7.72B
Cap. Flow
% of AUM
14.72%
Top 10 Holdings %
Top 10 Hldgs %
17.31%
Holding
2,462
New
319
Increased
921
Reduced
776
Closed
312
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$436M |
| 3 |
Apple
AAPL
|
+$415M |
| 4 |
Microsoft
MSFT
|
+$396M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booz Allen Hamilton
BAH
|
+$120M |
| 2 |
Walt Disney
DIS
|
+$115M |
| 3 |
Wingstop
WING
|
+$89.6M |
| 4 |
Cisco
CSCO
|
+$88.1M |
| 5 |
Amphenol
APH
|
+$84.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.78% |
| 2 | Healthcare | 10.33% |
| 3 | Financials | 10.22% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Industrials | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Arcus Biosciences
RCUS
$3.57B
| $626K | ﹤0.01% |
76,919
-25,739
| -25% | -$220K |
|
|
PRSU
1652
Pursuit Attractions and Hospitality Inc
PRSU
$1.43B
| $625K | ﹤0.01% |
+21,676
| New | +$639K |
|
1653
Universal Electronics
UEIC
$57.2M
| $624K | ﹤0.01% |
94,259
+22,343
| +31% | +$137K |
|
|
FLOC
1654
Flowco Holdings
FLOC
$843M
| $621K | ﹤0.01% |
+34,844
| New | +$666K |
|
|
PRO
1655
DELISTED
PROS Holdings
PRO
| $614K | ﹤0.01% |
39,219
+22,403
| +133% | +$381K |
|
1656
Xeris Biopharma Holdings
XERS
$1.44B
| $611K | ﹤0.01% |
130,849
-44,398
| -25% | -$203K |
|
|
CLDT
1657
Chatham Lodging
CLDT
$630M
| $609K | ﹤0.01% |
87,422
-91,172
| -51% | -$636K |
|
1658
Myers Industries
MYE
$1.18B
| $606K | ﹤0.01% |
41,833
-82,104
| -66% | -$1M |
|
1659
Hillman Solutions
HLMN
$1.56B
| $603K | ﹤0.01% |
84,400
-9,800
| -10% | -$73.4K |
|
1660
Perella Weinberg Partners
PWP
$1.14B
| $602K | ﹤0.01% |
+30,984
| New | +$547K |
|
1661
MiMedx Group
MDXG
$626M
| $601K | ﹤0.01% |
98,360
+31,064
| +46% | +$207K |
|
1662
PACCAR
PCAR
$69.6B
| $598K | ﹤0.01% |
6,292
-1,701
| -21% | -$157K |
|
1663
IHS Holding
IHS
$2.77B
| $593K | ﹤0.01% |
106,733
-44
| -0% | -$237 |
|
1664
Rogers Corp
ROG
$2.33B
| $592K | ﹤0.01% |
8,648
-9,302
| -52% | -$600K |
|
|
PINE
1665
Alpine Income Property Trust
PINE
$339M
| $592K | ﹤0.01% |
40,242
-119
| -0.3% | -$1.84K |
|
1666
InterDigital
IDCC
$6.68B
| $590K | ﹤0.01% |
2,630
-18,589
| -88% | -$3.94M |
|
1667
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.35B
| $588K | ﹤0.01% |
+21,352
| New | +$563K |
|
|
ITOS
1668
DELISTED
iTeos Therapeutics
ITOS
| $586K | ﹤0.01% |
58,768
+36,236
| +161% | +$292K |
|
1669
Corteva
CTVA
$59.7B
| $582K | ﹤0.01% |
+7,808
| New | +$520K |
|
1670
PUT
Freeport-McMoran
FCX
$90B
| $581K | ﹤0.01% |
+13,400
| New | +$509K |
|
|
OPRA
1671
Opera Ltd
OPRA
$1.65B
| $579K | ﹤0.01% |
+30,639
| New | +$525K |
|
1672
Varex Imaging
VREX
$460M
| $571K | ﹤0.01% |
65,838
+29,177
| +80% | +$238K |
|
1673
Essent Group
ESNT
$6.06B
| $571K | ﹤0.01% |
9,399
-3,722
| -28% | -$215K |
|
1674
Viemed Healthcare
VMD
$451M
| $570K | ﹤0.01% |
82,498
+18,025
| +28% | +$122K |
|
|
EWCZ
1675
DELISTED
European Wax Center
EWCZ
| $568K | ﹤0.01% |
+100,941
| New | +$459K |
|
Similar funds
Man Group's Q2 2025 Portfolio in Review
As of Q2 2025, Man Group held 2,462 positions worth $52.5B, up 33% from $39.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Man Group deployed $7.72B of net new capital in Q2 2025, opening 319 new positions and adding to 921 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,900,024 shares worth $1.17B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Booz Allen Hamilton, an estimated $120M trimmed.
- Man Group's largest Q2 2025 buy was State Street SPDR S&P 500 ETF Trust: 1,900,024 shares worth $1.17B.
- Man Group added most to NVIDIA in Q2 2025, an estimated $436M increase.
- Man Group's biggest Q2 2025 reduction was Booz Allen Hamilton, cutting an estimated $120M.
- Man Group fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $81.9M.
- Man Group's ten largest holdings make up 17% of its $52.5B portfolio in Q2 2025.
- Man Group opened 319 new positions and closed 312 in Q2 2025.
- Man Group's portfolio value rose 33% quarter-over-quarter to $52.5B.
Based on Man Group's 13F filing for Q2 2025, filed 14 Aug 2025.